Stocks and Investing
Stocks and Investing
Fri, April 21, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Gil Blum Reiterated (AUTL) at Strong Buy and Held Target at $7 on, Apr 21st, 2023
Gil Blum of Needham, Reiterated "Autolus Therapeutics plc" (AUTL) at Strong Buy and Held Target at $7 on, Apr 21st, 2023.
Gil has made no other calls on AUTL in the last 4 months.
There are 2 other peers that have a rating on AUTL. Out of the 2 peers that are also analyzing AUTL, 0 agree with Gil's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Gil
- Yanan Zhu of "Wells Fargo" Initiated at Buy and Held Target at $8 on, Monday, March 27th, 2023
- Mara Goldstein of "Mizuho" Maintained at Strong Buy with Decreased Target to $12 on, Wednesday, March 8th, 2023
Contributing Sources